A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors | Clinical Trial
In addition to providing excellent care for women with cervical cancer, we lead a number of clinical trials to improve on current standards for treatment and enhance survival and quality of life. We lead clinical trials through our research programs as well as through the efforts of the Gynecologic Oncology Group, a multi-institutional clinical research effort supported by the National Cancer Institute.
Clinical trials are research studies that evaluate the safety and effectiveness of new ways to diagnose and treat cervical cancer. These studies can also help doctors compare the effectiveness of prevention strategies or other aspects of your care.
Our clinical research team is highly experienced in selecting women who are mostly likely to benefit from a particular investigational therapy and in guiding patients through the process of enrolling in the most appropriate clinical trial. If you are eligible to participate in a clinical trial, you may have access to new therapies that are not yet widely available.
The following cervical cancer clinical trials at Memorial Sloan Kettering are currently enrolling patients. To learn more about a study, choose from the list below.